Clinical Trials

Showing trials with last updates posted in 2021.

NCT03579888 | TERMINATED | PHASE1
4 participants

CD19-Specific T Cells Post AlloSCT

Study Type:
INTERVENTIONAL
Last Updated:
2021-06-02
Start Date:
2020-06-26
Completion:
2021-05-27
Conditions
  • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Ph-Like Acute Lymphoblastic Leukemia
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory Mantle Cell Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Ph-Like Acute Lymphoblastic Leukemia
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT01983800 | COMPLETED | NA
60 participants

AnaConDa Long Term Sedation Study

Study Type:
INTERVENTIONAL
Last Updated:
2021-06-02
Start Date:
2013-07-31
Completion:
2018-02-28
Conditions
  • Intubated Requiring Sedation for Greater Than 48 Hours
Interventions
  • DRUG
No Results Yet
NCT01927913 | WITHDRAWN | PHASE2
0 participants

Treatment of Iron Overload Requiring Chelation Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2021-06-02
Start Date:
2014-11-20
Completion:
2015-10-30
Conditions
  • Transfusional Iron Overload
  • Iron Overload
  • Iron Chelation
  • Beta-thalassemia
  • Transfusional Hemosiderosis
  • Iron Metabolism Disorders
  • Metabolic Diseases
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page